As diabetes care continues to be a major focus, new treatments are arising. Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in incretin mimetic medications. While all work to https://socialmarkz.com/story12908099/retatrutide-vs-tirzepatide-vs-semaglutide-a-direct-analysis